Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of TAS-102 in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

NCT03762161 is registered in ClinicalTrials.gov with Rahul Parikh as lead sponsor.

NCT NCT03762161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of TAS-102 in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer
Lead sponsor
Rahul Parikh
Phase
Phase 2
Overall status
Unknown status
Start date
January 3, 2019
Completion date
January 31, 2024
Enrollment
22 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer